As the burden of metabolic disorders continues to rise globally, the need for scalable and sustainable solutions becomes increasingly urgent
Dihexa has a completely unknown human safety profile with a plausible theoretical mechanism for serious harm (c-Met-mediated oncogenesis)
The supernatant was adjusted to have 150 mM of NaCl, 2 mM of MgCl 2, and 20 mM of imidazole
To view or add a comment, sign in More Relevant Posts GLP-1 use among U.S
In particular, the review focuses on summarizing how the increase of gut microbial metabolite TMAO affects CVDs including atherosclerosis, heart failure, hypertension, arrhythmia, coronary artery disease, and other CVD-related diseases
Oncotarget 8 (33), 5495154965